Breaking News
4816 - 4830 of 6634 results
Prev
320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next
June 24, 2008
WuXi PharmaTech and Covance have entered into a Memorandum of Understanding to create a 50/50 joint venture to provide preclinical contract research services in China. Operations of the proposed joint venture will be located in a 323,450-sq.-ft., pur…
Read More »
June 24, 2008
The FDA has extended by three months its review of the NDA for Effient, which was previously known by its generic name of prasugrel. The drug's application was accepted in February 2008 and its deadline for action was this week. The new action date i…
Read More »
June 24, 2008
Diana Wood has been named vice president, business development for Stason Pharmaceuticals, where she will be responsible for all business development functions, including guiding the company's global business development activities. Ms. Wood is a sen…
Read More »
June 23, 2008
Penn Pharmaceutical Services U.S. Inc, asubsidiary of UK-based Penn Pharmaceutical Services Ltd., has expanded its clinical trial supplies distribution capabilities with the opening of a 75,000-sq.-ft., temperature-controlled storage and distribution…
Read More »
June 23, 2008
Dr. Patrice Hugo has been named vice president of scientific affairs for the global central lab network of MDS Pharma Services. In this role, he will lead the development of innovative biomarkers and esoteric assays to enhance clinical development pr…
Read More »
June 23, 2008
Stiefel Laboratories will acquire Barrier Therapeutics for approximately $148 million. The parties expect the transaction to close by the end of the third quarter of 2008.
"This acquisition demonstrates our continued commitment to advancing t…
Read More »
June 20, 2008
Rentschler Biotechnologie has started operation of a 2,500 L multi-process production suite for its bio-CMO operations. The company now has nine stand-alone GMP suites with volumes of 30, 250, 500 and 2,500 liters, allowing the production of material…
Read More »
June 20, 2008
Sigma-Aldrich has entered into a five-year collaboration to develop optimal cell lines for the production of monoclonal antibodies. Scientists at the University of California, San Francisco will lead the research into antibodies for a variety of canc…
Read More »
June 20, 2008
India-based Intas Biopharmaceuticals Ltd. has acquired Biologics Process Development, based in Poway, CA. With the acquisition process underway, both Intas Biopharma and BPD are actively pursuing plans to work closely toward fulfillment of common bus…
Read More »
June 19, 2008
Millie Tan has been named senior vice president, Global Marketing and chief marketing officer, and David Coman has been named senior vice president, Communications and Patient Recruitment at Quintiles Transnational.
"Both Dave and Millie brin…
Read More »
June 19, 2008
PacificGMP and Pacific Biopharma Group (PBG) have signed a definitive merger agreement and will develop a cGMP biologics CMO in Taizhou, China. At approximately 200,000 sq. ft., the new CMO, called China Quantitative Biomedicine (CQB), will be one of…
Read More »
June 18, 2008
Freda C. Lewis-Hall, M.D. has been named executive vice president, Medicines Development, of Vertex Pharmaceuticals. Dr. Lewis-Hall joins Vertex from Bristol-Myers Squibb, and has extensive leadership experience across multiple functional areas in th…
Read More »
June 18, 2008
Pfizer has entered into an agreement with generics manufacturer Ranbaxy Laboratories Ltd. of India to settle all their patent litigation worldwide involving Lipitor. Under the terms of the agreement, Ranbaxy will have a license to sell generic versio…
Read More »
June 18, 2008
Patheon has selected locations in Research Triangle Park (RTP) and Durham, NC for its global headquarters and new analytical development laboratory facilities.
Said Wes Wheeler, chief executive officer and president of Patheon Inc., "Patheon…
Read More »
June 17, 2008
Appian Labs, a biopharmaceutical company specializing in advanced therapeutic design, has launched itself as a company focused on providing comprehensive and strategic drug delivery and design solutions for pharmaceutical and other bioactives compani…
Read More »
4816 - 4830 of 6634 results
Prev
320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 337 338 339 340 341 342 343 344 345 346 347 348 349 350 351 352 353 354 355 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 377 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 407 408 409 410 411 412 413 414 415 416 417 418 419 420 421 422 423 424 425 426 427 428 429 430 431 432 433 434 435 436 437 438 439 440 441 442 443
Next



